DE3105303C2 - 2-Tetrahydrofuranyl- und 2-Tetrahydropyranyl-Sulfoniumverbindungen, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel - Google Patents

2-Tetrahydrofuranyl- und 2-Tetrahydropyranyl-Sulfoniumverbindungen, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel

Info

Publication number
DE3105303C2
DE3105303C2 DE3105303A DE3105303A DE3105303C2 DE 3105303 C2 DE3105303 C2 DE 3105303C2 DE 3105303 A DE3105303 A DE 3105303A DE 3105303 A DE3105303 A DE 3105303A DE 3105303 C2 DE3105303 C2 DE 3105303C2
Authority
DE
Germany
Prior art keywords
tetrahydro
compounds
furanyl
chj
sulfide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE3105303A
Other languages
German (de)
English (en)
Other versions
DE3105303A1 (de
Inventor
Mikio Gifu Hori
Akihide Koda
Katsuo Naruto Tokushima Takikawa
Yuji Tokushima Yamada
Ichiro Yamawaki
Mitsugi Yasumoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taiho Pharmaceutical Co Ltd
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP1838580A external-priority patent/JPS56123977A/ja
Priority claimed from JP850081A external-priority patent/JPS57122074A/ja
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Publication of DE3105303A1 publication Critical patent/DE3105303A1/de
Application granted granted Critical
Publication of DE3105303C2 publication Critical patent/DE3105303C2/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Photolithography (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE3105303A 1980-02-15 1981-02-13 2-Tetrahydrofuranyl- und 2-Tetrahydropyranyl-Sulfoniumverbindungen, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel Expired DE3105303C2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1838580A JPS56123977A (en) 1980-02-15 1980-02-15 Sulfonium compound and its preparation
JP850081A JPS57122074A (en) 1981-01-21 1981-01-21 Sulfonium compound and its preparation

Publications (2)

Publication Number Publication Date
DE3105303A1 DE3105303A1 (de) 1981-12-17
DE3105303C2 true DE3105303C2 (de) 1985-01-03

Family

ID=26343021

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3105303A Expired DE3105303C2 (de) 1980-02-15 1981-02-13 2-Tetrahydrofuranyl- und 2-Tetrahydropyranyl-Sulfoniumverbindungen, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel

Country Status (10)

Country Link
US (1) US4581372A (https=)
AU (1) AU522849B2 (https=)
CA (1) CA1169080A (https=)
CH (1) CH647771A5 (https=)
DE (1) DE3105303C2 (https=)
ES (1) ES500077A0 (https=)
FR (1) FR2476084A1 (https=)
GB (1) GB2070597B (https=)
IT (1) IT1172224B (https=)
NL (1) NL8100753A (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4556737A (en) * 1983-03-11 1985-12-03 Taiho Pharmaceutical Company Limited Sulfonium compounds, processes for preparing the compounds and pharmacological composiitons containing the same
JPH0621072B2 (ja) * 1986-11-12 1994-03-23 呉羽化学工業株式会社 エストラジオ−ル誘導体よりなる免疫調節剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2562042A (en) * 1949-09-19 1951-07-24 American Home Foods Inc Tetrahydropyran-sulfide compounds
US3455956A (en) * 1965-02-24 1969-07-15 Takeda Chemical Industries Ltd Dialkyl-sulfoxides and dialkyl-sulfones
DE2332709A1 (de) * 1972-06-30 1974-01-10 Ciba Geigy Ag Verfahren zur herstellung von sulfoniumsalzen
IT1045036B (it) * 1975-02-19 1980-04-21 Zambon Spa Derivato del dimercaptoetil etere

Also Published As

Publication number Publication date
GB2070597A (en) 1981-09-09
US4581372A (en) 1986-04-08
AU6723481A (en) 1981-08-20
ES8201568A1 (es) 1982-01-01
DE3105303A1 (de) 1981-12-17
CA1169080A (en) 1984-06-12
NL8100753A (nl) 1981-09-16
GB2070597B (en) 1983-07-27
FR2476084A1 (fr) 1981-08-21
ES500077A0 (es) 1982-01-01
IT8167206A0 (it) 1981-02-13
CH647771A5 (de) 1985-02-15
IT1172224B (it) 1987-06-18
AU522849B2 (en) 1982-07-01
FR2476084B1 (https=) 1983-07-08

Similar Documents

Publication Publication Date Title
DE69230824T2 (de) Neue tetrapeptidderivate
DE3408708C2 (de) Sulfoniumverbindungen, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzung
DE1670048C3 (de) Neue Norscopolaminderivate
DD290186A5 (de) Verfahren zur herstellung von piperidinderivaten
DE1951748A1 (de) Fluoranthenester
DE2523103A1 (de) Neue propargyl-2-phenylamino-imidazoline-(2), deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zur herstellung derselben
DE3105303C2 (de) 2-Tetrahydrofuranyl- und 2-Tetrahydropyranyl-Sulfoniumverbindungen, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
DE1770242C3 (de) Dibenzo [b,e] [1,4] thiazepine, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Mittel
DD258608A1 (de) Verfahren zur herstellung neuer thieno(2,3-alpha)-imidazolderivate
CH668973A5 (de) Purin-derivate, ihre herstellung und sie enthaltende arzneimittel.
AT391316B (de) Neue thienyloxy-alkylamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2211397C3 (https=)
EP0313935B1 (de) Enolether von 6-Chlor-4-hydroxy-2-methyl-N-(2-pyridyl)-2H-thieno(2,3-e)-1,2-thiazin-3-carbonsäureamid-1,1-dioxid, ein Verfahren zu ihrer Herstellung sowie ihre Verwendung
DE2831094A1 (de) Bis-(nitrosoureido)-polyolderivate, solche enthaltende arzneimittel und verfahren zur herstellung derselben sowie di-(ureido)-polyolderivate
DE2636866A1 (de) Neue phenothiazinderivate und deren herstellung
DE2410201B2 (de) 6-substituierte 3-carbaethoxyhydrazinopyridazine beziehungsweise ihre salze sowie solche enthaltende arzneimittel und verfahren zur herstellung derselben
DE3326384A1 (de) 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
DE2921844A1 (de) Neue nitrosoharnstoff-verbindungen, ein verfahren zu deren herstellung sowie therapeutische zubereitung
DE2318575A1 (de) Neue oxazolidinone
DE3242204A1 (de) Verfahren zur herstellung von aminoalkylfuranen oder -thiophenen
EP0138034A1 (de) Substituierte Pyrido(1,2-c)imidazo((1,2-a)benzimidazole, Verfahren zu ihrer Herstellung, ihre Verwendung sowie pharmazeutische Präparate auf Basis dieser Verbindungen
DE3107599C2 (de) N-Cyan-N'-methyl-N"-{2-[(5-methylthio-imidazol-4-yl)-methylthio]-äthyl}-guanidin, Verfahren zu seiner Herstellung und diese Verbindung enthaltende Arzneimittel
DE2633692A1 (de) 1,2,3,4-tetrahydroisochinoline, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE2740852A1 (de) Basische 1-acylindol-3-acetocyessigsaeureester, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE2854725A1 (de) Polyfluorisopropyl-substituierte tricyclische carbostyrile, verfahren zu ihrer herstellung undd sie enthaltende arzneimittel

Legal Events

Date Code Title Description
OP8 Request for examination as to paragraph 44 patent law
D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee